Senescent T cells: a potential biomarker and target for cancer therapy

• Main Authors: Jie Zhang, Tianhui He, Lixiang Xue, Hongyan Guo
• Format: Article
• Language: English
• Published: Elsevier 2021-06-01
• Series: EBioMedicine
• Subjects: Senescent T cell; tumour microenvironment; cancer immunotherapy; prognostic biomarkers; therapeutic targets
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352396421002024

The failure of T cells to eradicate tumour cells in the tumour microenvironment is mainly due to the dysfunction of T cells. Senescent T cells, with defects in proliferation and effector functions, accumulate in ageing, chronic viral infections, and autoimmune disorders where antigen stimulation persists. Increasing evidence suggests that inducing T cell senescence is a key strategy used by malignant tumours to evade immune surveillance. In this review, we summarize the general features, functional regulation, and signalling network of senescent T cells in tumour development and highlight their potential as prognostic biomarkers in multiple cancer treatments, including chemotherapy, radiotherapy, and immunotherapy. Moreover, we discuss possible therapeutic strategies for preventing or rejuvenating senescence in tumour-specific T cells. Understanding these critical issues may provide novel strategies to enhance cancer immunotherapy.